Laboratorios Richmond SACIF (RICH) — Capital Reinvestment Ratio

Latest as of June 2025: 9.90x

Laboratorios Richmond SACIF (RICH) has a Capital Reinvestment Ratio of 9.90x as of June 2025, meaning it reinvests 10% of its operating cash flow (AR$760.81 Million) in capital expenditures (AR$7.53 Billion). See Laboratorios Richmond SACIF (RICH) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

9.90x
Capex / Operating Cash Flow

Operating Cash Flow

AR$760.81 Million
ARS

Capital Expenditures

AR$7.53 Billion
ARS

Data as of

Jun 2025
Most recent filing

Laboratorios Richmond SACIF Capital Reinvestment Ratio (2006–2024)

This chart tracks Laboratorios Richmond SACIF's Capital Reinvestment Ratio across 9 annual periods.

Annual Capital Reinvestment Ratio for Laboratorios Richmond SACIF (2006–2024)

Year-by-year Capital Reinvestment Ratio for Laboratorios Richmond SACIF from 2006 to 2024. For live market cap and broader valuation context, see Laboratorios Richmond SACIF (RICH) market capitalisation.

Year Reinvestment Ratio Operating CF (ARS) Capital Expenditures YoY Change
2024 1.57x AR$5.62 Billion AR$8.81 Billion ▲ +10.4%
2021 1.42x AR$7.27 Billion AR$10.32 Billion ▼ -54.7%
2019 3.13x AR$121.02 Million AR$378.66 Million ▼ -54.4%
2017 6.86x AR$11.18 Million AR$76.68 Million ▲ +157.3%
2011 2.67x AR$3.51 Million AR$9.37 Million ▲ +39.2%
2010 1.92x AR$8.30 Million AR$15.90 Million ▲ +52.3%
2009 1.26x AR$1.25 Million AR$1.58 Million ▲ +14.3%
2007 1.10x AR$6.73 Million AR$7.42 Million ▲ +16.1%
2006 0.95x AR$12.87 Million AR$12.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow